NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

FII Latest News: Nureca on 15 Jan 2025

[fetch_key]
[fetch_key]
A pivotal factor in the performance of markets is the involvement of FIIs (Foreign Institutional Investors), which encompass a range of foreign entities investing in domestic companies. These large international investors infuse significant capital flows into the market, influencing both short-term price movements and setting the tone for long-term market trends. Their strategic investments enhance market liquidity and project global interest in the local economic scene. FIIs are frequently viewed as a barometer of foreign economic sentiment, as their market participation is heavily influenced by global economic conditions. Consequently, their investment activities have a profound and far-reaching impact on stock prices, market sentiment, and ultimately, the financial health of the host country.
Amid evolving economic conditions, FIIs are recalibrating their portfolios, reflecting keen sensitivity to international market signals. This strategic adaptation is evidenced in their recent transactions involving companies like Choksi Laboratories and Nureca . Detailed insights into these activities are outlined in the table below.

Recent Bulk Deals:

Company Client Name Buy/Sell Qty Traded Price Trader Name
Choksi Laboratories Nexus Global Opportunities Fund Buy 35K 114.01 Na
Nureca Copthall Mauritius Investment Buy 116K 401.94 Na

Choksi Laboratories :

35K shares were purchased by Nexus Global Opportunities Fund through Foreign Institutional Investments, executed at a price of ₹114.01 per share. This action underlines a significant alteration in the stock, signaling the broad spectrum of interest from foreign investors, whether buying or selling.

Nureca :

116K shares were purchased by Copthall Mauritius Investment through Foreign Institutional Investments, executed at a price of ₹401.94 per share. This activity reveals a substantial fluctuation in the stock, demonstrating the ongoing involvement of foreign investors in both acquiring and divesting.

[my_shortcode values=”Choksi Laboratories , Nureca “]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post